Immunogenicity and safety of a new hexavalent vaccine (DTaP5-IPV-HB-Hib) administered in a mixed primary series schedule with a pentavalent vaccine (DTaP5-IPV-Hib).

Federico Martinón-Torres,Florence Boisnard,Stéphane Thomas,Christine Sadorge,Ray Borrow

Vaccine（2017）

引用 9|浏览12

暂无评分

摘要

•DTaP5-IPV-HB-Hib induced acceptable response rates against hepatitis B and Hib.•Different Hib conjugates in the schedule do not compromise immunogenicity/safety.•Results support administration of DTaP5-IPV-HB-Hib in a mixed primary series schedule.

查看译文

关键词

DTaP5-IPV-HB-Hib,Primary series,Mixed schedule,Vaccine immune response,Safety profile

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要